The long, discouraging quest for a medication that works to treat Alzheimer’s reached a potentially promising milestone. For the first time in a large clinical trial, a drug was able to both reduce the plaques in the brains of patients and slow the progression of dementia.
More extensive trials will be needed to know if the new drug is truly effective, but if the results, presented at the Alzheimer’s Association International Conference in Chicago, are borne out, the drug may be the first to successfully attack both the brain changes and the symptoms of Alzheimer’s.
Learn more: New Alzheimer’s Drug Shows Big Promise in Early Trial Results